| 1 |
29874257 | Evaluation of the innate immunostimulatory potential of originator and non-originator copies of insulin glargine in an in vitro human immune model. | 2018 |
2 |
| 2 |
25697343 | Proliferative and signaling activities of insulin analogues in endometrial cancer cells. | 2015 May 5 |
2 |
| 3 |
23653049 | Differences in metabolic and mitogenic signallingof insulin glargine and AspB10 human insulin in rats [corrected]. | 2013 Aug |
3 |
| 4 |
23251042 | A docking study of insulin with LI-CR-L2 ecto domain of insulin receptor: an easy way for preliminary screening of novel anti-diabetic peptides. | 2012 |
2 |
| 5 |
20209060 | In vitro metabolic and mitogenic signaling of insulin glargine and its metabolites. | 2010 Mar 4 |
3 |
| 6 |
20835859 | Long-acting insulin analogues elicit atypical signalling events mediated by the insulin receptor and insulin-like growth factor-I receptor. | 2010 Dec |
1 |
| 7 |
19145584 | Insulin analogues display IGF-I-like mitogenic and anti-apoptotic activities in cultured cancer cells. | 2009 Jan |
1 |
| 8 |
18316392 | Proliferation of colo-357 pancreatic carcinoma cells and survival of patients with pancreatic carcinoma are not altered by insulin glargine. | 2008 Jun |
2 |
| 9 |
18585815 | Characteristics of signalling properties mediated by long-acting insulin analogue glargine and detemir in target cells of insulin. | 2008 Sep |
1 |
| 10 |
14656737 | Glargine and regular human insulin similarly acutely enhance endothelium-dependent vasodilatation in normal subjects. | 2004 Feb |
1 |
| 11 |
15281015 | Reduced action of insulin glargine on protein and lipid metabolism: possible relationship to cellular hormone metabolism. | 2004 Aug |
1 |